Innoviva, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ABOS
|
Acumen Pharmaceuticals, Inc. | $2.24 | $157.41 M | -2.5 | 51 | $0 |
 AMLX
|
Amylyx Pharmaceuticals, Inc. | $5.30 | $120.37 M | -1.65 | 384 | $380.79 M |
 APLS
|
Apellis Pharmaceuticals, Inc. | $26.20 | $4.90 B | -11.77 | 702 | $396.59 M |
 ARGX
|
argenx SE | $567.60 | $22.33 B | -66.05 | 1148 | $1.23 B |
 DAWN
|
Day One Biopharmaceuticals, Inc. | $13.00 | $1.12 B | -5.11 | 174 | $0 |
 DNLI
|
Denali Therapeutics Inc. | $24.18 | $2.96 B | -22.1 | 390 | $330.53 M |
 EFTR
|
eFFECTOR Therapeutics, Inc. | $0.00 | $6.16 M | -0.1 | 14 | $0 |
 ELEV
|
Elevation Oncology, Inc. | $0.55 | $192.87 M | -4.15 | 29 | $0 |
 FOLD
|
Amicus Therapeutics, Inc. | $9.66 | $2.98 B | -20.51 | 500 | $399.36 M |
 HOOK
|
HOOKIPA Pharma Inc. | $2.79 | $79.07 M | -1.71 | 151 | $20.13 M |
 HRMY
|
Harmony Biosciences Holdings, Inc. | $33.07 | $1.73 B | 13.15 | 246 | $582.02 M |
 INCY
|
Incyte Corporation | $76.98 | $13.30 B | 17.93 | 2524 | $3.70 B |
 INZY
|
Inozyme Pharma, Inc. | $2.88 | $286.39 M | -3.43 | 59 | $0 |
 LIFE
|
aTyr Pharma, Inc. | $1.90 | $131.12 M | -2.16 | 56 | $353,000 |
 MRTX
|
Mirati Therapeutics, Inc. | $58.70 | $4.12 B | -4.82 | 587 | $12.44 M |
 PDSB
|
PDS Biotechnology Corporation | $2.01 | $106.92 M | -2.13 | 25 | $0 |
 PLX
|
Protalix BioTherapeutics, Inc. | $1.64 | $82.11 M | 14 | 208 | $65.49 M |
 TERN
|
Terns Pharmaceuticals, Inc. | $5.69 | $462.44 M | -5.67 | 66 | $0 |
 XFOR
|
X4 Pharmaceuticals, Inc. | $0.38 | $169.62 M | -1.51 | 127 | $0 |